NOVONIX Ltd Files Form 6-K for October 2025
Ticker: NVNXF · Form: 6-K · Filed: Oct 27, 2025 · CIK: 1859795
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, reporting
TL;DR
NOVONIX filed its monthly 6-K report with the SEC on Oct 27, 2025. Standard procedure.
AI Summary
NOVONIX Limited, a foreign private issuer, filed a Form 6-K on October 27, 2025, for the month of October 2025. The company is incorporated in Australia and its principal executive office is located in Brisbane. NOVONIX is required to file annual reports under Form 20-F.
Why It Matters
This filing indicates that NOVONIX is meeting its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate increased risk.
Key Players & Entities
- NOVONIX Ltd (company) — Registrant
- Form 6-K (document) — Filing type
- October 2025 (date) — Reporting period
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on October 27, 2025.
What is NOVONIX Limited's principal executive office address?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does NOVONIX Limited file annual reports under Form 20-F or Form 40-F?
NOVONIX Limited indicates it files annual reports under cover of Form 20-F.
Is NOVONIX Limited a US-based company?
No, NOVONIX Limited is a foreign private issuer with a non-US business address in Brisbane, Australia.
Filing Stats: 192 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2025-10-27 06:20:41
Filing Documents
- nvx-6k-oct-25--27_form_6.htm (6-K) — 27KB
- nvx-ex99_1.htm (EX-99.1) — 86KB
- 0001193125-25-250632.txt ( ) — 114KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Robert Long Robert Long Chief Financial Officer Date: October 27, 2025